Obiettivo MeMed has completed development of ImmunoXpert™, an in vitro diagnostic test that leverages the body’s immune system to accurately differentiate between bacterial and viral infections. A breakthrough in infectious disease diagnosis, ImmunoXpert™ overcomes limitations of traditional diagnostics, outperforming standard of care. ImmunoXpert™ recently received regulatory European clearance (CE-IVD) and represents a close-to-market innovation. Market entry points include emergency department and hospitalized pediatric patients with respiratory tract infections (RTI) and fever without source (FWS), for which ImmunoXpert™ is uniquely positioned to improve patient management and health economics. In children, RTIs account for 50% of doctor visits and hospitalization. Fever accounts for 10-25% of pediatric ED visits, with as many as 20% without identifiable source. The global market for ImmunoXpert™ diagnosis of pediatric RTI/FWS is €2.8B (EU is €560M).To fast track market adoption across Europe we propose:•To transition ImmunoXpert™ from a hands-on laboratory assay to Tecan’s hands-free, rapid automated laboratory platform to increase clinical utility and economic benefit•To roll-out ImmunoXpert™ to EU pilot hospitals with the goal of managing 1200 pediatric patients to evaluate performance and clinical utility in real working conditions•To perform health economics analysis and establish reimbursement strategy AutoPilot-Dx is a cross sector effort (industry, KOLs, outcome researchers) highly aligned with H2020-FTIPilot’s goals and Societal Challenges: it will reduce ImmunoXpert™’s time to market and provide a road-map for sustainable market uptake; a H2020 first-time applicant is involved; the project will enable MeMed and Tecan to scale-up in line with their business strategies; the immune-based diagnostics will improve antibiotic stewardship, providing better, personalized, care for children with RTI/FWS and help fight antibiotic resistance – a global health threat Campo scientifico medical and health scienceshealth sciencesinfectious diseasesmedical and health sciencesbasic medicineimmunologymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibioticssocial scienceseconomics and businesseconomicshealth economicsmedical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance Programma(i) H2020-EC - Horizon 2020 Framework Programme Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2. - PRIORITY 'Industrial leadership' Argomento(i) FTIPilot-1-2015 - Fast Track to Innovation Pilot Invito a presentare proposte H2020-FTIPilot-2015-1 Vedi altri progetti per questo bando Meccanismo di finanziamento IA - Innovation action Coordinatore MEMED DIAGNOSTICS LTD Contribution nette de l'UE € 655 025,00 Indirizzo NAHUM HETH STREET 5 39120 TIRAT CARMEL Israele Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 938 250,00 Partecipanti (5) Classifica in ordine alfabetico Classifica per Contributo netto dell'UE Espandi tutto Riduci tutto QUANTIFY RESEARCH AB Svezia Contribution nette de l'UE € 437 500,00 Indirizzo HANTVERKARGATAN 8 112 21 STOCKHOLM Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Östra Sverige Stockholm Stockholms län Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 625 000,00 TECAN DEUTSCHLAND GMBH Germania Contribution nette de l'UE € 370 125,00 Indirizzo WERNER VON SIEMENS STR. 23 74564 CRAILSHEIM Mostra sulla mappa Regione Baden-Württemberg Stuttgart Schwäbisch Hall Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 528 750,00 UNIVERSITA DEGLI STUDI DI MILANO Partecipazione conclusa Italia Contribution nette de l'UE € 26 937,50 Indirizzo Via Festa Del Perdono 7 20122 Milano Mostra sulla mappa Regione Nord-Ovest Lombardia Milano Tipo di attività Higher or Secondary Education Establishments Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 26 937,50 RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG Germania Contribution nette de l'UE € 415 625,00 Indirizzo SEMINARSTRASSE 2 69117 Heidelberg Mostra sulla mappa Regione Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis Tipo di attività Higher or Secondary Education Establishments Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 415 625,00 UNIVERSITA DEGLI STUDI DI PERUGIA Italia Contribution nette de l'UE € 388 687,50 Indirizzo PIAZZA DELL UNIVERSITA 1 06123 Perugia Mostra sulla mappa Regione Centro (IT) Umbria Perugia Tipo di attività Higher or Secondary Education Establishments Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 388 687,50
